Our Chief Strategy & Process Development Officer, Karen Wen, Ph.D., gave a talk to share the opportunities and challenges of CAR-T in gene and cell therapy in the Forum of Frontiers in Cell Therapy II in Taipei on August 28, 2019.
Our EVP., CTO/COOEVP/ COO and CTO, Dr. Chien-Tsun Kuan, delivered a company presentation in BIO-Asia, on July 25, 2019. This presentation received lots of attention.
Our EVP/COO & CTO, Dr. Chien-Tsun Kuan, hosted a session- Cell & gene therapy with six distinguished speakers sharing about their experiences in Bio-Asia Taiwan on July 26, 2019. The session content is very fruitful and got lots discussion. It is a very productive session.
Our Chief strategy & Product development Officer, Karen Wen, Ph.D. gave a company presentation in Taiwan Chamber of Commerce of New England (TCCNE) and shared with the audience about our progress on June 24, 2019.
Our EVP/ COO and CTO, Dr. Chien-Tsun Kuan, Ph.D. gave a company presentation in Boston Chinese Investment Club (BCIC), USA on June 23, 2019. This presentation rouse lots attention in our non-viral nucleofection platform and company’s potential.
Our EVP/COO & CTO, Dr. Chien-Tsun Kuan, gave the presentation “Adoptive Cell TherapyCAR-T Cell Therapy” in Post-SITC conference in New Taipei City, Taiwan on March 24, 2019.
Our EVP/COO & CTO, Dr. Chien-Tsun Kuan, gave the presentation “CAR-T Cell Therapy Development for Solid Tumor Treatment-Challenges & Opportunities” in BioProcess International Asia/Cell Therapy Manufacturing Asia in Tokyo, Japan on February 27, 2019.
Dr. Karen Wen on behalf of chairman of biological drug committee of CPMDA chaired two conferences about “ Application and Execution of Clinical Trials about Cell Therapy” in Taipei, Taiwan on October 3 and November 20, 2018.
Our founder and CEO, Sareina Wu, Ph.D. shared her experience in “Talk with CEO'‘ in Taipei, Taiwan on May 10, 2018.